NMN/NR (Nicotinamide Mononucleotide/Riboside) Cost in North Dakota 2026

What Does NMN or NR Actually Cost in North Dakota Right Now?

The average cash-pay price for a one-month supply of NMN or NR at North Dakota retail pharmacies and supplement outlets in 2026 is approximately $80. Branded over-the-counter products sold at national chains such as Walmart, Target, and independent health-food stores in Fargo, Bismarck, and Grand Forks typically fall between $50 and $120 per month depending on dose and brand. Compounded nicotinamide mononucleotide from a licensed 503A pharmacy may be priced differently based on dose, excipients, and the individual pharmacy's compounding fee.

Prices vary meaningfully by dose. A 250 mg/day capsule regimen costs less than a 500 mg or 1 to 000 mg protocol. The Yoshino et al. randomized controlled trial published in Science (2021, N=25 postmenopausal women with prediabetes) used 250 mg/day oral NMN for 10 weeks and documented increases in skeletal muscle NAD+ content and improvements in insulin signaling gene expression [1]. That trial dose is at the lower end of what most commercial products offer, which partly explains why higher-dose products carry steeper price tags.

NR (nicotinamide riboside) products are sold under brand names including Tru Niagen and Elysium Basis. A 300 mg/day NR regimen via Tru Niagen retails for roughly $40 to $50 per month when purchased directly, while a 500 mg/day protocol can reach $70 to $90. The 2023 randomized trial by Dollerup et al. used 1 to 000 mg/day NR and found significant increases in whole-blood NAD+ at 12 weeks [2]. Higher doses cost more, and North Dakota residents ordering online pay the same national retail price plus any applicable shipping.

Compounded NMN from a 503A pharmacy often ranges from $60 to $150 per month depending on the prescribed dose and the specific compounding pharmacy. Patients should request an itemized quote before committing, because compounding fees for NMN can add $20 to $40 per fill on top of ingredient cost.

Is NMN or NR Covered by North Dakota Medicaid?

North Dakota Medicaid does not cover NMN or NR in any formulation. Both compounds are classified as dietary supplements under federal law, and the Centers for Medicare and Medicaid Services (CMS) explicitly excludes dietary supplements from Medicaid reimbursement unless a state has obtained a specific waiver, which North Dakota has not done for NAD precursors [3].

The North Dakota Department of Human Services administers Medicaid through its Behavioral Health Division and traditional fee-for-service programs. None of those programs list nicotinamide mononucleotide or nicotinamide riboside on their preferred drug lists as of January 2026 [4].

Medicare Part D similarly does not reimburse supplements. Patients enrolled in a Medicare Advantage plan in North Dakota, including plans offered by Sanford Health Plan or Blue Cross Blue Shield of North Dakota, will not receive coverage for NMN or NR under their drug benefit.

For low-income North Dakota residents, the most practical cost-reduction strategies are: purchasing a lower-dose OTC product (250 mg/day), using a manufacturer subscription discount (typically 15 to 25 percent off single-purchase pricing), or asking a telehealth provider whether a compounded formulation is clinically appropriate and whether the compounding pharmacy offers a lower per-milligram cost than retail brands.

Is Compounded Nicotinamide Mononucleotide Legal in North Dakota?

Compounded NMN is legally available in North Dakota through 503A pharmacies. Yes, with conditions.

A 503A pharmacy operates under Section 503A of the Federal Food, Drug, and Cosmetic Act and may compound NMN for individual patients when a licensed prescriber issues a valid, patient-specific prescription [5]. The North Dakota State Board of Pharmacy regulates these pharmacies and requires that compounded preparations meet United States Pharmacopeia (USP) standards for identity, strength, quality, and purity.

The FDA's position on NMN is relevant here. In 2022, the FDA issued a citizen petition response indicating that NMN had been investigated as a new drug before being marketed as a supplement, which raised questions about its legal status as a dietary ingredient under 21 U.S.C. 321(ff) [6]. That determination complicated but did not eliminate the pathway for compounding. A 503A pharmacy compounding for an individual patient under a prescription operates under a different legal framework than a dietary supplement manufacturer, so compounding pharmacies in North Dakota have continued to prepare NMN for patients under physician or nurse practitioner orders.

Patients and providers should verify that the chosen compounding pharmacy:

• Holds a valid North Dakota State Board of Pharmacy license
• Sources NMN from an FDA-registered bulk drug substance supplier
• Performs or contracts out certificate-of-analysis (CoA) testing for purity and potency
• Complies with USP Chapter 795 standards for non-sterile preparations

503B outsourcing facilities are a separate category and are not the relevant pathway for individual patient prescriptions in North Dakota. 503B facilities supply healthcare institutions, not individual patients through a prescriber [5].

Can North Dakota Residents Get NMN or NR Through Telehealth?

Telehealth prescribing of NMN and NR is legal in North Dakota. A licensed provider holding a valid North Dakota prescribing license may evaluate a patient via synchronous audio-video telehealth and issue a prescription for compounded NMN without an in-person visit, consistent with North Dakota Century Code Chapter 43-17 governing medical practice and the state's telehealth parity law [7].

The practical workflow for a North Dakota patient is straightforward. The patient completes an intake form with a telehealth platform, a provider reviews labs (typically a metabolic panel and possibly a NAD+ functional marker), a prescription is sent to a 503A compounding pharmacy, and the medication ships directly to the patient's home address. Turnaround is commonly five to ten business days from initial consultation to delivery.

Audio-only telehealth, without video, is permitted for established patients under North Dakota's telehealth statute but may not satisfy the prescribing requirements for a new controlled or compounded substance at every platform's discretion. Patients should confirm the visit modality with the specific telehealth provider before scheduling.

HealthRX providers are licensed in North Dakota and can evaluate patients for NMN or compounded NAD precursor therapy using this telehealth framework.

Does Any Insurance Plan Cover NMN or NR in North Dakota?

No major commercial insurer covers NMN or NR in North Dakota as of 2026. Blue Cross Blue Shield of North Dakota, Sanford Health Plan, and Medica (which operates in the ND marketplace) do not list nicotinamide mononucleotide or nicotinamide riboside as covered benefits under their pharmacy or medical formularies [8].

This is consistent with the national picture. NMN and NR lack an FDA-approved indication as pharmaceutical drugs. The FDA has not approved any NMN or NR product under a New Drug Application (NDA) or Biologics License Application (BLA). Without an approved indication, insurers have no obligation under ACA essential health benefit rules to cover these compounds, and none have elected to do so voluntarily.

Health savings accounts (HSA) and flexible spending accounts (FSA) present a partial workaround. Compounded NMN prescribed by a licensed provider is generally considered a qualified medical expense under IRS Publication 502 when the prescription is issued for a specific medical purpose, allowing pre-tax dollars to offset cost [9]. OTC NMN supplements purchased without a prescription are not FSA/HSA-eligible.

Patients with an HSA-eligible high-deductible health plan through an ND employer can use their HSA funds for the compounded prescription version, effectively reducing a $100/month cost by 22 to 37 percent depending on their marginal tax bracket.

What Is the Science Behind NMN and NR? Why Do Providers Prescribe Them?

NAD+ (nicotinamide adenine dinucleotide) declines with age in human tissue. By age 60, skeletal muscle NAD+ levels may be 50 percent lower than at age 20, based on data from muscle biopsy studies analyzed by Janssens et al. [10]. NMN and NR are both precursors that the body converts to NAD+ via the salvage biosynthesis pathway, which is more efficient in most tissues than the de novo tryptophan pathway.

The science is promising but still maturing.

The Yoshino et al. Science 2021 trial (N=25) showed that 250 mg/day oral NMN for 10 weeks significantly increased NAD+ metabolites in skeletal muscle and improved insulin sensitivity signaling compared to placebo, specifically upregulating expression of genes involved in muscle remodeling (P<0.05 for several transcriptomic endpoints) [1]. The trial was small, but its mechanistic findings were well-controlled.

A separate 2020 phase 1 clinical trial by Fukamizu et al. (N=10, single ascending dose up to 500 mg) confirmed that oral NMN is rapidly absorbed, with peak plasma NMN detected at 2.5 hours post-dose, and is converted to circulating NMN metabolites including NAD+ in blood [11]. No serious adverse events were reported.

For NR specifically, the Elysium-funded BASIS trial and the ChromaDex-sponsored work by Trammell et al. showed that 1 to 000 mg/day NR for six weeks increased whole-blood NAD+ by approximately 2.7-fold compared to baseline in healthy adults [12]. The effect was dose-dependent and reversible after discontinuation.

Animal data, particularly in mouse models using NMN, have shown improvements in muscle function, energy metabolism, and cardiovascular parameters. The Yoshino et al. Cell Metabolism 2011 paper (mouse model) showed NMN reversed age-associated physiological decline in energy metabolism, insulin sensitivity, and lipid metabolism [13]. Mouse data do not translate directly to humans, but they motivated the human trials now underway.

The HealthRX clinical decision framework for NAD precursor therapy in North Dakota patients uses three tiers:

Tier 1 (OTC, self-directed): Patient purchases 250 to 500 mg/day NMN or 300 mg/day NR over the counter. No prescription needed. Cost: $50 to $80/month. Appropriate for generally healthy adults interested in longevity optimization without specific metabolic diagnoses.

Tier 2 (Telehealth-prescribed, compounded NMN): Provider evaluates the patient, orders baseline labs (fasting glucose, HbA1c, comprehensive metabolic panel, optional NAD+ functional marker), prescribes compounded NMN 250 to 500 mg/day from a licensed ND 503A pharmacy. Cost: $60 to $150/month plus consultation fee. Appropriate for patients with prediabetes, metabolic syndrome, or documented fatigue with low NAD+ functional markers.

Tier 3 (Integrated protocol): Compounded NMN combined with other metabolic interventions (metformin, GLP-1 agonist if indicated, lifestyle protocol). Provider monitors labs at 12 weeks. Cost: variable. Appropriate for patients with type 2 diabetes, obesity (BMI <40 with comorbidities), or documented age-related metabolic decline.

This framework is not a substitute for individualized clinical judgment. Providers should review the patient's full medication list before prescribing; concurrent use of NMN with PARP inhibitors or CD38 inhibitors may theoretically alter NAD+ metabolism [14].

Safety Profile and What North Dakota Patients Should Know Before Starting

NMN and NR are generally well tolerated in trials completed to date. The most common adverse effects reported in the Yoshino 2021 trial were mild gastrointestinal symptoms (nausea, loose stools) in fewer than 10 percent of participants at 250 mg/day [1]. Higher doses used in NR trials (1 to 000 mg/day) showed similar tolerability, with no serious adverse events reported in the Trammell et al. crossover study [12].

Flushing, which is a known adverse effect of nicotinic acid (niacin), is not typically seen with NMN or NR because neither compound activates the GPR109A receptor responsible for niacin-induced flushing [15].

Drug interactions are not well characterized in humans. Theoretical concerns exist around:

• Concurrent use of high-dose niacin (additive NAD precursor load)
• Chemotherapy agents that target NAD+ metabolism (NAMPT inhibitors)
• Sirtuin-activating compounds such as resveratrol, where combinatorial effects on NAD+ are unstudied in controlled human trials

Patients in North Dakota on any active cancer treatment should consult their oncologist before starting NMN or NR, because NAD+ supports DNA repair pathways that could theoretically affect tumor response to certain therapies [14].

Pregnant and breastfeeding patients should avoid NMN and NR. No adequate safety data exist for these populations, and the FDA has not evaluated these compounds for use during pregnancy [6].

How to Get the Best Price on NMN or NR in North Dakota

The lowest-cost legitimate options for North Dakota residents in 2026, ranked by monthly out-of-pocket cost, are:

Option 1: OTC 250 mg/day NMN via subscription. Brands such as Renue By Science, ProHealth Longevity, and DoNotAge offer subscription pricing that reduces cost to approximately $40 to $55 per month. No prescription needed. Quality varies; look for products with third-party CoA testing (Informed Sport, NSF, or USP verification).

Option 2: OTC NR 300 mg/day. Tru Niagen 300 mg subscription runs approximately $40/month. Elysium Basis (NR + pterostilbene 50 mg) runs approximately $50/month on subscription. Both are available to ND residents via direct online order.

Option 3: Compounded NMN via telehealth prescription. Cost depends on the compounding pharmacy. Telehealth consultation fees range from $75 to $150 for an initial visit at most platforms. Ongoing prescriptions without further consultation can reduce total monthly cost once established. HSA/FSA dollars may apply.

Option 4: Buying in bulk. Purchasing a three-month supply at once reduces per-unit cost by 10 to 20 percent at most supplement brands. This strategy works best after a patient has confirmed tolerability over the first 30 days.

No state-specific North Dakota discount program exists for NMN or NR as of January 2026. The North Dakota Prescription Connection program, which helps residents access manufacturer patient-assistance programs, does not list NMN or NR because neither compound has an FDA-approved drug status that would qualify it for pharmaceutical PAP programs [16].

Manufacturer discount codes and referral programs are the primary savings mechanism available. These are brand-specific and change quarterly; patients should check directly with the manufacturer's website for current offers.

The single most cost-effective move for most North Dakota patients is choosing a well-tested 250 mg/day NMN or 300 mg/day NR OTC product on subscription, then re-evaluating with a telehealth provider at 12 weeks based on symptom response and any relevant lab changes. A standard metabolic panel costs $30 to $60 at a Quest or LabCorp draw site in Fargo or Bismarck without insurance.